Peer Review channel feed – Endpoints News

Peer Review channel feed

RNA biotech Arcturus boots CEO Joseph Payne

8 years ago

Heptares co-founder Fiona Marshall to lead Merck's London research hub; Ablynx appoints Robert Friesen as new CFO

8 years ago

Big Pharma vet John Hohneker takes the reins at Anokion; Heptares co-founder Fiona Marshall resigns from parent company Sosei

8 years ago

Why did Ablynx board chairman Peter Fellner resign in wake of Novo's buyout offer?; Amgen vet Richard Paulson tapped to run Ipsen North America

8 years ago

Sanuj Ravindran to lead PellePharm as CEO; Paul Hastings leaves OncoMed; Moderna taps John Mendlein as president

8 years ago

Synergy CEO passes torch to CCO Troy Hamilton; President Steven Kafka resigns from Foundation; AbbVie vet John Leonard to helm Intellia

8 years ago

Andy Boyer joins Teva exodus; Achaogen shuffles executive lineup

8 years ago

Grail taps Genentech vet Jennifer Cook as CEO, building expectations for 2018

8 years ago

Novartis oncology CEO Bruno Strigini is calling it quits

8 years ago

Cynthia Collins exits Human Longevity; Section 32 welcomes Michael Pellini; Silverback beefs up its C-suite

8 years ago

Daniel Swisher leaves an ailing Sunesis and swoops in to lead Jazz Pharmaceuticals

8 years ago

Laura Shawver hits the ground running, scouting new investors for tiny Synthorx

8 years ago

Teva boots its R&D chief; Ironwood grows the C-suite and Intercept taps new EVP of research

8 years ago

Pfizer reshuffles top ranks with Albert Bourla as COO; Intra-cellular nabs Novartis vet Andrew Satlin as CMO

8 years ago

Annalisa Jenkins' next career chapter takes her back to Europe

8 years ago

Celgene's Michael Pehl leaps up to lead role at Immunomedics; GSK nabs Hal Barron to helm R&D; Aimmune CEO to step down

8 years ago

Grail vet Bajaj aims for some broad influence with Foresite bucks

8 years ago

Peer Review: aTyr promotes data expert Sanjay Shukla as CEO

8 years ago

Biotech Peer Review: Magenta onboards five new VPs; BioInvent is hunting for a new CEO

8 years ago

Peer Review: Eyeing a $350M venture fund, Nextech recruits Third Rock’s Jakob Loven for the team

8 years ago

Biotech entrepreneur Saurabh Saha moves to translational research chief at Bristol-Myers; Ex-GSK pharma chief Hussain switches to private equity

8 years ago

David Meeker starts a new biotech chapter in his career; Sam Kulkarni takes the helm at CRISPR

8 years ago

Chris Carpenter joins the R&D exodus out of pharma; George Church's eGenesis selects Jodie Morrison as new CEO

8 years ago

GSK vets Witty and Slaoui find new roles in biotech as the great migration continues

8 years ago

First page Previous page 14 15 161718 Next page Last page